Page last updated: 2024-08-24
tangeretin and flutax 2
tangeretin has been researched along with flutax 2 in 1 studies
Research
Studies (1)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Feng, SL; Liu, L; Liu, ZQ; Ma, WZ; Xie, Y; Yao, XJ; Yuan, ZW | 1 |
Other Studies
1 other study(ies) available for tangeretin and flutax 2
| Article | Year |
|---|---|
Tangeretin, a citrus pentamethoxyflavone, antagonizes ABCB1-mediated multidrug resistance by inhibiting its transport function.
Topics: A549 Cells; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; ATP Binding Cassette Transporter, Subfamily B; Binding Sites; Caco-2 Cells; Cell Survival; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Flavones; G2 Phase Cell Cycle Checkpoints; Humans; Inhibitory Concentration 50; Molecular Docking Simulation; Neoplasms; Paclitaxel; Protein Binding; Protein Conformation; Structure-Activity Relationship; Taxoids; Time Factors | 2016 |